Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
temozolomide (temodar) (1 trial)
t lymphocytes (1 trial)
Brain Neoplasms (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Gliosarcoma (Phase 2)
Trials (1 total)
Trial APIs (2 total)